nCode

nCode Bio is an innovative AI/ML powered generative Sequence as a Service (SqAAS) suite that empower researchers discover, validate and derisk novel “multi-omic” sequences for enabling next generation therapeutics.
‍AI/ML-enabled drug discovery suite combined with leveraging the expertise in early R&D to late stage therapeutic development programs in cell and gene therapy (CGT), genomics, immuno-oncology, CRISPR, iPSCs, and biotherapeutics nCode delivers efficient, effective and safe sequences

Key features include:

• Advanced generative AI and LLMs.
• Novel target discovery and mapping targets to existing disease indications.
• Robotic micro-experiments with integrated analyses enabling de-risking and accelerating the discovery and development funnel.
• Short turnaround times.
• Cross-disciplinary approach.
• Immunogenicity prediction/ risk assessment.